You are using an older browser version. Please use a supported version for the best MSN experience.

3 Global Value Stocks to Buy Now

The Motley Fool logo The Motley Fool 4/29/2021 Zhiyuan Sun
a group of people sitting at a desk looking at a laptop: 3 Global Value Stocks to Buy Now © Provided by The Motley Fool 3 Global Value Stocks to Buy Now

With the average stock on the S&P 500 trading at lofty levels of 42.7 times earnings (P/E), it's becoming harder and harder to find high-quality stocks trading for fair prices. One surprising area to look for them is the realm of American Depository Receipts (ADRs), or companies that do their principal business outside of the country, but trade on a U.S. exchange.

Three firms that are among the top of this category are Sify Technologies (NASDAQ: SIFY)ContextLogic (NASDAQ: WISH), and 111 Inc. (NASDAQ: YI). Let's look at why now's the time to go long on the India data center company, the discount e-commerce firm in Europe, and the leading telepharmacy giant in China. 

a group of people sitting at a desk in front of a laptop computer: People meeting in boardroom with virtual participant on screen © Getty Images People meeting in boardroom with virtual participant on screen

1. Sify Technologies 

Sify Technologies holds a leading position in the Indian telecom sector, but is rapidly transitioning out of the industry due to fierce competition and razor-thin margins. It has found a perhaps more lucrative role in powering the country's emerging IT infrastructure. The company has 10 data centers servicing 10,000 enterprise clients across India. It plans to more than double that number within the next four years.

Sify's data center segment has witnessed 21% year over year. The firm's customers range from automakers, pharma companies, to power plants and payment solution providers. In third-quarter 2021 (ended Dec. 31), its sales and earnings improved by 7% and 54% over Q3 2020, respectively, to INR 6.301 billion (Rupees) and INR 252 million. Over the past five years, the company saw steady revenue and earnings growth of 8% and 10% per year.

Investors should see those numbers shoot higher after the company's software and data system segment takes over that of its legacy telecom operations. For now, the company remains a bargain tech stock trading at just 1.7 times sales and about 49 times earnings.

2. ContextLogic (Wish)

ContextLogic is the brains behind the e-commerce platform, Wish. Unlike its competitors Amazon (NASDAQ: AMZN) and Shopify (NYSE: SHOP), the only thing this company cares about when it comes to its customers is pricing. Wish sells its discount and unbranded merchandise directly from manufacturers in China, saving the costs of branding, marketing, and support that are passed on to consumers.


Gallery: 15 Robinhood Stocks That You Shouldn't Overlook (The Motley Fool)

It undoubtedly has a business model that prioritizes cheapness above all else (even the shopping experience) -- but it's a surprisingly popular one. Believe it or not, Wish is the No. 1 shopping app in over 42 countries. It has over 107 million monthly active users.

Last year, the company's revenue grew by 34% year over year to $2.5 billion, including a 193% increase in logistics revenue. What's more, the number of partner merchants on its platform grew by a stunning 435% to 550,000.

Wish operates in over 100 countries, but is especially popular in Europe; 46% of its sales come from the continent. Last year, the company completed a $1.1 billion IPO to scale its operations. For now, Wish has found itself doing quite well in a niche market. I think the stock is a buy, especially while it trades at just above 3 times revenue.

3. 111 Inc.

Don't let the nondescript name throw you off. 111 is currently the No. 1 telepharmacy company in China and is looking to disrupt the CNY 300 billion (Yuan) retail pharmacy industry in the country. It partners with 57% of retail pharmacies, or 300,000 stores, across the country to deliver its medications and health products. 111 offers branded medications, generic drugs, vitamins, contact lenses, beauty products, and more.

111 is also expanding into telemedicine to create a one-stop platform for all healthcare needs. After consultation with a physician on a partner service, patients can have their prescription delivered to their doorstep. Recently, it began to offer liver and gallbladder drugs on its platform as part of a broader move into helping people manage chronic diseases.

Last year, the company's sales grew by 107.6% over 2019 to $1.26 billion. Simultaneously, its net loss went from 11% of revenue to 4.6%. Sales of one-time coronavirus pandemic supplies (like masks) helped fuel its growth for much of the year. However, the company still expects to increase its sales by 63% year over year in 2021. With its stock trading at just 0.8 times revenue, this is one of the cheapest healthcare growth stocks investors can buy right now.

SPONSORED:

10 stocks we like better than ContextLogic Inc.

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and ContextLogic Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of February 24, 2021

 

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Zhiyuan Sun owns shares of 111 INC. The Motley Fool owns shares of and recommends Amazon and Shopify. The Motley Fool recommends the following options: long January 2022 $1920.0 calls on Amazon and short January 2022 $1940.0 calls on Amazon. The Motley Fool has a disclosure policy.

AdChoices
AdChoices
AdChoices

More from The Motley Fool

The Motley Fool
The Motley Fool
image beaconimage beaconimage beacon